Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desvenlafaxine SR in Pediatric MDD
NCT01371734Phase 3Completed
- Sponsor
- Pfizer
- Start
- Aug 2011
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of desvenlafaxine in major depressive disorder (MDD), sponsored by Pfizer. Started Aug 2011; status: completed.
02
Drugs
desvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01371734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01371734.